DM Intelligence is an artificial intelligence development company that built AI
solutions for
small molecule drugs with high specific and affinity. Our proprietary platform, Artificial
Intelligence Drug
Discovery Platform (AI-DDP), integrates artificial intelligence technologies into the medical
field to
provide better service to pharmaceutical companies, academic centers and biotech companies.
AI-DDP allow us to optimize leads with specific desired properties as well as design
small
molecules targeting specific site or receptor. Our platform has extensive capabilities of
analyzing and
predicting physicochemical properties, biological and toxicological activities of candidate
drugs based on
their structures. With all these techniques, we strive for break thoughts in the future of drug
discovery
and research.
Cooperation
Products
Hit Identification
Predictive Models
Founder/CEO WeiDong Xie
PhD. Imperial College London.
Professor, Sun Yat-sen University
Director, St. Jude Children's Research Hospital
CTO, CK Life Science Group
CEO Lindan Biotech, Canada.
VP Biotherapy Inc
Dr. RiQiang Deng
Professor, Sun Yat-sen University
Bioinformatics scientist IT, and AI, deep learning, neural network.
Dr. Da-Wei Gu
PhD. Imperial College London
Professor in Engineering, University of Leicester
Research interests include robust control, optimal control, optimization algorithms.
Chartered Engineer
a Fellow of IET
Dr.PingHua Sun
At present, he is the head of Department of pharmacy, School of pharmacy, Jinan University
Master of pharmaceutical chemistry, Shenyang Pharmaceutical University
Doctor of Biomedical Engineering, Jinan University
University of South Florida School of Medicine / Moffitt Cancer Institute postdoctoral
College of pharmacy,Jinan University:Assistant(2002-2004)
College of pharmacy,Jinan University:lecturer(2004-2010)
College of pharmacy,Jinan University:associate professor/Master Tutor(2010-2015)
College of pharmacy,Jinan University:professor/Doctoral supervisor(2015-Now)
Partners
News
DM Intelligence Raises Approximately ￥10 Million CNY ($1.5M USD) in Angel Round for Advance AI + Drug Discovery
